Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Wallington

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Gut|September 1, 1972
Levels of salivary IgA in treated and untreated coeliac diseaseT Wallington, A B Ajdukiewicz, A E Read, et al.
International Journal of Molecular Sciences|April 28, 2023
Ferroptosis in Haematological Malignancies and Associated Therapeutic NanotechnologiesRachel L Mynott, Ali Habib, Oliver G Best, et al.
Postgraduate Medical Journal|March 1, 1991
Alopecia totalis and vitiligo in common variable immunodeficiencyG Spickett, A G Prentice, T Wallington, et al.
Discover Oncology|August 25, 2025
The instrumental role of lipids in governing the sensitivity of multiple myeloma to ferroptosisAli Habib, Oliver G Best, Charlotte E Toomes, et al.
Journal of Clinical & Laboratory Immunology|April 1, 1986
C3 nephritic factor in an individual with recurrent viral infection and lipodystrophyB Myers, R Chambers, A Anderson, et al.
Autophagy|April 5, 2011
FTY720 produces caspase-independent cell death of acute lymphoblastic leukemia cellsCraig T Wallington-Beddoe, John Hewson, Kenneth F Bradstock, et al.
Clinical and Experimental Immunology|January 1, 1981
IgG rheumatoid factor, complement and immune complexes in rheumatoid synovitis and vasculitis: comparative and serial studies during cytotoxic therapyD G Scott, P A Bacon, C Allen, et al.
Cell Death Discovery|July 6, 2021
Author Correction: Targeting sphingolipid metabolism as an approach for combination therapies in haematological malignanciesAlexander C Lewis, Craig T Wallington-Beddoe, Jason A Powell, et al.
British Journal of Haematology|April 21, 2018
Resistance to proteasome inhibitors and other targeted therapies in myelomaCraig T Wallington-Beddoe, Magdalena Sobieraj-Teague, Bryone J Kuss, et al.
Cell Death Discovery|August 1, 2018
Targeting sphingolipid metabolism as an approach for combination therapies in haematological malignanciesAlexander C Lewis, Craig T Wallington-Beddoe, Jason A Powell, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Gut|September 1, 1972
Levels of salivary IgA in treated and untreated coeliac diseaseT Wallington, A B Ajdukiewicz, A E Read, et al.
International Journal of Molecular Sciences|April 28, 2023
Ferroptosis in Haematological Malignancies and Associated Therapeutic NanotechnologiesRachel L Mynott, Ali Habib, Oliver G Best, et al.
Postgraduate Medical Journal|March 1, 1991
Alopecia totalis and vitiligo in common variable immunodeficiencyG Spickett, A G Prentice, T Wallington, et al.
Discover Oncology|August 25, 2025
The instrumental role of lipids in governing the sensitivity of multiple myeloma to ferroptosisAli Habib, Oliver G Best, Charlotte E Toomes, et al.
Journal of Clinical & Laboratory Immunology|April 1, 1986
C3 nephritic factor in an individual with recurrent viral infection and lipodystrophyB Myers, R Chambers, A Anderson, et al.
Autophagy|April 5, 2011
FTY720 produces caspase-independent cell death of acute lymphoblastic leukemia cellsCraig T Wallington-Beddoe, John Hewson, Kenneth F Bradstock, et al.
Clinical and Experimental Immunology|January 1, 1981
IgG rheumatoid factor, complement and immune complexes in rheumatoid synovitis and vasculitis: comparative and serial studies during cytotoxic therapyD G Scott, P A Bacon, C Allen, et al.
Cell Death Discovery|July 6, 2021
Author Correction: Targeting sphingolipid metabolism as an approach for combination therapies in haematological malignanciesAlexander C Lewis, Craig T Wallington-Beddoe, Jason A Powell, et al.
British Journal of Haematology|April 21, 2018
Resistance to proteasome inhibitors and other targeted therapies in myelomaCraig T Wallington-Beddoe, Magdalena Sobieraj-Teague, Bryone J Kuss, et al.
Cell Death Discovery|August 1, 2018
Targeting sphingolipid metabolism as an approach for combination therapies in haematological malignanciesAlexander C Lewis, Craig T Wallington-Beddoe, Jason A Powell, et al.
Pageof 5